long intergenic non-protein coding RNA 1411Genealiases: []
Q-omics provides the consensus-scored LINC01411 profile across patient tissues and cancer cell-line models. LINC01411 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in UCEC. Among the 18 cancer types available for tumor–normal comparison, LINC01411 is differentially expressed in 13, with the highest sampling consensus in COAD. Additionally, LINC01411 RNA expression shows 9,759 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight UCEC, COAD, and TGCT as cancer lineages where LINC01411 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01411 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01411 survival associations across molecular data types. LINC01411 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01411 RNA expression–survival associations across cancer types. High LINC01411 expression shows unfavorable associations in KIRC, LUAD, THCA and UCS, but favorable associations in UCEC and BRCA. The UCEC Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p = .001). Together, the overview and detailed table identify UCEC as the clearest survival context for LINC01411 RNA expression.
This table summarizes LINC01411 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 13. The strongest signals are observed in UCEC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01411. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01411 shows higher tumor expression in COAD, UCEC, BLCA, HNSC, KIRP and KIRC. The COAD box plot shows higher LINC01411 RNA expression in tumor versus normal tissue (log2 FC = +0.867, t-test p < 0.001).
This table shows molecular features associated with LINC01411 in patient tissues and cancer cell lines. In patient samples, LINC01411 shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set.
